ID

32480

Description

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00938418

Link

https://clinicaltrials.gov/show/NCT00938418

Keywords

Versions (1)
  1. 11/2/18 11/2/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 2, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Stage III Non-Small Cell Lung Cancer NCT00938418

English

Eligibility Stage III Non-Small Cell Lung Cancer NCT00938418

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically proven (either histologic or cytologic) diagnosis of stage iiia or iiib non-small cell lung cancer; excluding patients with n3 disease based on supraclavicular or contralateral hilar adenopathy, or significant pleural /
Description

Non-Small Cell Lung Carcinoma TNM clinical staging | Exception Supraclavicular lymphadenopathy | Exception Hilar adenopathy Contralateral | Exception Pleural effusion | Exception Pericardial effusion

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0749155
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0149711
UMLS CUI [3,3]
C0441988
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0032227
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0031039
pericardial effusion.
Description

ID.2

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients for whom treatment is planned with a maximum dose of ≥ 66 gy to the ipsilateral brachial plexus
Description

Therapeutic procedure Brachial plexus Ipsilateral | Therapeutic procedure Dose Maximal

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0006090
UMLS CUI [1,3]
C0441989
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205289
greater than minimal, exudative, or cytologically positive pleural effusions
Description

Pleural effusion Greater Than Minimal | Exudative pleural effusion | Pleural effusion Cytologic Positive

Data type

boolean

Alias
UMLS CUI [1,1]
C0032227
UMLS CUI [1,2]
C0439093
UMLS CUI [1,3]
C0547040
UMLS CUI [2]
C3887491
UMLS CUI [3,1]
C0032227
UMLS CUI [3,2]
C0205471
UMLS CUI [3,3]
C1514241
≥ 10% weight loss within the past month
Description

Weight decreased Percentage Time Period

Data type

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C1948053
prior invasive malignancy (with exceptions)
Description

Invasive cancer

Data type

boolean

Alias
UMLS CUI [1]
C0677898
prior radiotherapy to the region of the study cancer
Description

Prior radiation therapy Region Cancer Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0205147
UMLS CUI [1,3]
C0006826
UMLS CUI [1,4]
C0008976
significant co-morbidities
Description

Comorbidity Significant

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0750502
pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception
Description

Pregnancy | Childbearing Potential Sexually active Contraceptive methods Unwilling | Gender Sexually active Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0241028
UMLS CUI [2,3]
C0700589
UMLS CUI [2,4]
C0558080
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0241028
UMLS CUI [3,3]
C0700589
UMLS CUI [3,4]
C0558080
known allergic reactions to components of planned chemotherapy regimen
Description

Allergic Reaction Component Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C1705248
UMLS CUI [1,3]
C0392920
Back to the top of the page

Similar models

Eligibility Stage III Non-Small Cell Lung Cancer NCT00938418

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging | Exception Supraclavicular lymphadenopathy | Exception Hilar adenopathy Contralateral | Exception Pleural effusion | Exception Pericardial effusion
Item
pathologically proven (either histologic or cytologic) diagnosis of stage iiia or iiib non-small cell lung cancer; excluding patients with n3 disease based on supraclavicular or contralateral hilar adenopathy, or significant pleural /
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0749155 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0149711 (UMLS CUI [3,2])
C0441988 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0032227 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0031039 (UMLS CUI [5,2])
ID.2
Item
pericardial effusion.
boolean
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Brachial plexus Ipsilateral | Therapeutic procedure Dose Maximal
Item
patients for whom treatment is planned with a maximum dose of ≥ 66 gy to the ipsilateral brachial plexus
boolean
C0087111 (UMLS CUI [1,1])
C0006090 (UMLS CUI [1,2])
C0441989 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205289 (UMLS CUI [2,3])
Pleural effusion Greater Than Minimal | Exudative pleural effusion | Pleural effusion Cytologic Positive
Item
greater than minimal, exudative, or cytologically positive pleural effusions
boolean
C0032227 (UMLS CUI [1,1])
C0439093 (UMLS CUI [1,2])
C0547040 (UMLS CUI [1,3])
C3887491 (UMLS CUI [2])
C0032227 (UMLS CUI [3,1])
C0205471 (UMLS CUI [3,2])
C1514241 (UMLS CUI [3,3])
Weight decreased Percentage Time Period
Item
≥ 10% weight loss within the past month
boolean
C1262477 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1948053 (UMLS CUI [1,3])
Invasive cancer
Item
prior invasive malignancy (with exceptions)
boolean
C0677898 (UMLS CUI [1])
Prior radiation therapy Region Cancer Clinical Trial
Item
prior radiotherapy to the region of the study cancer
boolean
C0279134 (UMLS CUI [1,1])
C0205147 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
Comorbidity Significant
Item
significant co-morbidities
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
Pregnancy | Childbearing Potential Sexually active Contraceptive methods Unwilling | Gender Sexually active Contraceptive methods Unwilling
Item
pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0241028 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
C0079399 (UMLS CUI [3,1])
C0241028 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
C0558080 (UMLS CUI [3,4])
Allergic Reaction Component Chemotherapy
Item
known allergic reactions to components of planned chemotherapy regimen
boolean
C1527304 (UMLS CUI [1,1])
C1705248 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial